Optic Nerve Glioma: Follow-up

References

1. Wilhelm H. Primary optic nerve tumours. Curr Opin Neurol. Feb 2009;22(1):11-8. [Medline].

2. Aoki S, Barkovich AJ, Nishimura K, et al. Neurofibromatosis types 1 and 2: cranial MR findings. Radiology. Aug 1989;172(2):527-34. [Medline].

3. Hendrix LE, Kneeland JB, Haughton VM, et al. MR imaging of optic nerve lesions: value of gadopentetate dimeglumine and fat-suppression technique. AJNR Am J Neuroradiol. Jul-Aug 1990;11(4):749-54. [Medline].

4. Messori A, Salvolini U. Hybrid phakomatosis: from initial CT observation to molecular studies. AJNR Am J Neuroradiol. Aug 2004;25(7):1297-8.

5. Listernick R, Charrow J, Greenwald MJ, et al. Optic gliomas in children with neurofibromatosis type 1. J Pediatr. May 1989;114(5):788-92. [Medline].

6. Hollander MD, FitzPatrick M, O''Connor SG, et al. Optic gliomas. Radiol Clin North Am. Jan 1999;37(1):59-71, ix. [Medline].

7. Millar WS, Tartaglino LM, Sergott RC, et al. MR of malignant optic glioma of adulthood. AJNR Am J Neuroradiol. Sep 1995;16(8):1673-6. [Medline].

8. Thiagalingam S, Flaherty M, Billson F. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology. Mar 2004;111(3):568-77. [Medline].

9. Kornreich L, Blaser S, Schwarz M, et al. Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. AJNR Am J Neuroradiol. Nov-Dec 2001;22(10):1963-9. [Medline].

10. Tumialan LM, Dhall SS, Biousse V. Optic nerve glioma and optic neuritis mimicking one another: case report. Neurosurgery. Jul 2005;57(1):E190; discussion E190.

11. Taylor T, Jaspan T, Milano G, Gregson R, Parker T, Ritzmann T, et al. Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br J Radiol. Oct 2008;81(970):761-6. [Medline].

12. Forte R, Cennamo G, Breve MA. Three-Dimensional Ultrasound of Ophthalmic Pathologies. Ophthalmologica. Jan 31 2009;223(3):183-187. [Medline].

13. Walrath JD, Engelbert M, Kazim M. Magnetic resonance imaging evidence of optic nerve glioma progression into and beyond the optic chiasm. Ophthal Plast Reconstr Surg. Nov-Dec 2008;24(6):473-5. [Medline].

14. Buffa A, Vannelli S, Peretta P. [NF1 and gliomas: the importance of the MRI]. Minerva Pediatr. Apr 2008;60(2):259-60. [Medline].

15. Kwon Y, Bae JS, Kim JM. Visual changes after gamma knife surgery for optic nerve tumors. Report of three cases. J Neurosurg. Jan 2005;102 Suppl:143-6.

Further Reading

Related eMedicine topics

Neurofibromatosis Type 1 (from Radiology)

Neurofibromatosis, Type 1 (from Neurology)

Optic Neuropathy, Compressive

Sudden Visual Loss (from Neurology)

Sudden Visual Loss (from Ophthalmology)

Clinical guidelines

Eye Examination in Infants, Children, and Young Adults by Pediatricians

Neurofibromatosis Type 1 in Genetic Counseling Practice: Recommendations of the National Society of Genetic Counselors

Clinical studies

Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas

Trial to Evaluate the Safety of Lovastatin in Adults With Neurofibromatosis Type I (NF1)

Keywords

optic nerve glioma, optic pathway glioma, optic glioma, neurofibromatosis, neurofibromatosis type 1, NF-1, neurofibromatosis 1, von Recklinghausen disease, optic nerve disease, hybrid phakomatosis

Contributor Information and Disclosures

Author

Richard J Woodcock Jr, MD, Consulting Radiologist, Atlanta Radiology Consultants, LLC; Consulting Radiologist and MRI Director, St Joseph's Hospital
Richard J Woodcock Jr, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Radiology, American Medical Association, American Roentgen Ray Society, American Society of Neuroradiology, Phi Beta Kappa, and Radiological Society of North America
Disclosure: Nothing to disclose.

Medical Editor

Barton F Branstetter IV, MD, Associate Professor of Radiology, Otolaryngology, and Biomedical Informatics, University of Pittsburgh; Director of Head and Neck Imaging, Clinical Director of Neuroradiology, Department of Radiology, Division of Neuroradiology, University of Pittsburgh Medical Center
Barton F Branstetter IV, MD is a member of the following medical societies: American College of Radiology, American Medical Association, American Roentgen Ray Society, American Society of Neuroradiology, Pennsylvania Medical Society, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

C Douglas Phillips, MD, Director of Head and Neck Imaging, Division of Neuroradiology, Weill Medical College of Cornell University/New York Presbyterian Hospital
C Douglas Phillips, MD is a member of the following medical societies: American College of Radiology, American Medical Association, American Society of Head and Neck Radiology, American Society of Neuroradiology, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, Resolution Imaging Medical Corporation
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Lawrence M Davis, MD, Assistant Professor of Diagnostic Imaging (Clinical), Department of Diagnostic Imaging, Warren Alpert Medical School at Brown University
Lawrence M Davis, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, American Society of Neuroradiology, Radiological Society of North America, and Rhode Island Medical Society
Disclosure: Nothing to disclose.